Array Technologies, Inc. (ARRY) Failed to Disclose Rising Costs Would Have an Adverse Effect on its Business Operations Array’s Offering Materials stated that one of the Company’s strengths related to

RenovaCare, Inc. (RCAR) Had Defective Disclosure Controls and Procedures that Caused its Stock Price to be Materially Inflated   On May 28, 2021, the SEC issued a release stating it

Ebix, Inc. (EBIX) Misled Shareholders About the Adequacy of its Internal Controls Over Financial Reporting On February 19, 2021, after the market closed, Ebix revealed that its independent auditor, RSM

Stable Road Acquisition Corp. (SRAC) Made Misstatements Regarding its Business Prospects On October 7, 2020, Stable Road and Momentus issued a joint press release announcing that Stable Road had agreed

Orphazyme A/S (ORPH) Misstated the Efficacy of its Drug Arimoclomal in its IPO Offering Documents      Orphazyme held a public offering in September 2020 based on negligently prepared offering documents. 

360 DigiTech, Inc. (QFIN) Made False and Misleading Statements Regarding its Business, Operations, and Prospects    During the relevant period, defendants touted the Company’s dedication to privacy protections and data

Kanzhun Limited (BZ) Misled the Investing Public Regarding Its Cybersecurity Risks    On July 5, 2021, Kanzhun announced that it was “subject to cybersecurity review by” the Cyberspace Administration of

James River Group Holdings, Ltd. (JRVR) Misled the Investing Public Regarding the Impact of Uber on the Company’s Reserves   In 2014, James River entered into a novel agreement with

CarLotz, Inc. (LOTZ, LOTZW) Made False and Misleading Statements Regarding its Business, Operations, and Prospects    CarLotz, Inc. became a public entity via merger with Acamar Partners Acquisition Corp., a